More than a Half-Century with Haloperidol: Glories, Disparities, and Use Today

References

• Agar, M. R., Lawlor, P. G., Quinn, S., Draper, B., Caplan, G. A., Rowett, D., Sanderson, C., Hardy, J., Le, B., Eckermann, S., McCaffrey, N., Devilee, L., Fazekas, B., Hill, M., & Currow, D. C. (2017). Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: A randomized clinical trial. JAMA Internal Medicine, 177(1), 34–42. https://doi.org/10.1001/jamainternmed.2016.7491
   PubMed Web of Science ®Google Scholar
• Arnold, L. M., Strakowski, S. M., Schwiers, M. L., Amicone, J., Fleck, D. E., Corey, K. B., & Farrow, J. E. (2004). Sex, ethnicity, and antipsychotic medication use in patients with psychosis. Schizophrenia Research, 66(2–3), 169–175. https://doi.org/10.1016/S0920-9964(03)00102-6
   PubMed Web of Science ®Google Scholar
• Awouters, F. H., & Lewi, P. J. (2007). Forty years of antipsychotic drug research—From haloperidol to paliperidone—with Dr. Paul Janssen. Arzneimittel-Forschung, 57(10), 625–632. https://doi.org/10.1055/s-0031-1296660
   PubMed Web of Science ®Google Scholar
• Buhagiar, K., & Jabbar, F. (2019). Association of first- vs. second-generation antipsychotics with lipid abnormalities in individuals with severe mental illness: A systematic review and meta-analysis. Clinical Drug Investigation, 39(3), 253–273. https://doi.org/10.1007/s40261-019-00751-2
   PubMed Web of Science ®Google Scholar
• Campillo, A., Castillo, E., Vilke, G. M., Hopper, A., Ryan, V., & Wilson, M. P. (2015). First-generation antipsychotics are often prescribed in the emergency department but are often not administered with adjunctive medications. The Journal of Emergency Medicine, 49(6), 901–906. https://doi.org/10.1016/j.jemermed.2015.07.021
   PubMed Web of Science ®Google Scholar
• Carbon, M., Hsieh, C. H., Kane, J. M., & Correll, C. U. (2017). Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: A meta-analysis. The Journal of Clinical Psychiatry, 78(3), e264–e278. https://doi.org/10.4088/JCP.16r10832
   PubMed Web of Science ®Google Scholar
• Chen, V. C., Liao, Y. T., Lai, T. J., Lane, H. Y., Shao, W. C., Dewey, M., Lee, C. T., & Lu, M. L. (2015). Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study. Schizophrenia Research, 169(1-3), 406–411. https://doi.org/10.1016/j.schres.2015.10.005
   PubMed Web of Science ®Google Scholar
• Chung, H., Mahler, J. C., & Kakuma, T. (1995). Racial differences in treatment of psychiatric inpatients. Psychiatric Services (Washington, D.C.), 46(6), 586–591. https://doi.org/10.1176/ps.46.6.586
   PubMed Web of Science ®Google Scholar
• Cook, T. B., Reeves, G. M., Teufel, J., & Postolache, T. T. (2015). Persistence of racial disparities in prescription of first-generation antipsychotics in the USA. Pharmacoepidemiology and Drug Safety, 24(11), 1197–1206. https://doi.org/10.1002/pds.3819
   PubMed Web of Science ®Google Scholar
• Coralic, Z., Rader, E. S., Vinson, D. R., & Wilson, M. P. (2022). Haloperidol versus ziprasidone with concomitant medications and other predictors of physical restraint duration in the emergency department. The Journal of Emergency Medicine, 62(5), 636–647. https://doi.org/10.1016/j.jemermed.2021.12.018
   PubMed Web of Science ®Google Scholar
• Daumit, G. L., Crum, R. M., Guallar, E., Powe, N. R., Primm, A. B., Steinwachs, D. M., & Ford, D. E. (2003). Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States. Archives of General Psychiatry, 60(2), 121–128. https://doi.org/10.1001/archpsyc.60.2.121
   PubMed Web of Science ®Google Scholar
• de Filippis, R., De Fazio, P., Gaetano, R., Steardo, L., Cedro, C., Bruno, A., Zoccali, R. A., & Muscatello, M. R. A. (2021). Current and emerging long-acting antipsychotics for the treatment of schizophrenia. Expert Opinion on Drug Safety, 20(7), 771–790. https://doi.org/10.1080/14740338.2021.1910674
   PubMed Web of Science ®Google Scholar
• Dold, M., Samara, M. T., Li, C., Tardy, M., & Leucht, S. (2015). Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. The Cochrane Database of Systematic Reviews, 1, CD009831. https://doi.org/10.1002/14651858.CD009831.pub2
   PubMed Web of Science ®Google Scholar
• Gerlach, L. B., Kales, H. C., Kim, H. M., Zhang, L., Strominger, J., Covinsky, K., Teno, J., Bynum, J. P. W., & Maust, D. T. (2021). Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014–2016. Journal of the American Geriatrics Society, 69(6), 1479–1489. https://doi.org/10.1111/jgs.17085
   PubMed Web of Science ®Google Scholar
• Granger, B., & Albu, S. (2005). The haloperidol story. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists, 17(3), 137–140. https://doi.org/10.1080/10401230591002048
   PubMedGoogle Scholar
• Herbeck, D. M., West, J. C., Ruditis, I., Duffy, F. F., Fitek, D. J., Bell, C. C., & Snowden, L. R. (2004). Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients. Psychiatric Services (Washington, D.C.), 55(6), 677–684. https://doi.org/10.1176/appi.ps.55.6.677
   PubMed Web of Science ®Google Scholar
• Hudson, T. J., Cody, M., Armitage, T. L., Curtis, M. A., & Sullivan, G. (2005). Disparities in use of antipsychotic medications among nursing home residents in Arkansas. Psychiatric Services (Washington, D.C.), 56(6), 749–751. https://doi.org/10.1176/appi.ps.56.6.749
   PubMed Web of Science ®Google Scholar
• Johnson, D. A. (2009). Historical perspective on antipsychotic long-acting injections. The British Journal of Psychiatry. Supplement, 52, S7–S12. https://doi.org/10.1192/bjp.195.52.s7
   PubMedGoogle Scholar
• Kennedy, J. M., Kunzler, N. M., & Hayes, B. D. (2022). Intravenous haloperidol has a limited role in the modern emergency department. Annals of Emergency Medicine. Advance online publication. https://doi.org/10.1016/j.annemergmed.2022.07.008
   Google Scholar
• Khalid, Z., Fana, M., Payea, R., Rutledge, K., Shah, B., Janssen, F., Ragina, N., & Zyzanski, S. J. (2019). Disparities and variables associated with physical restraint for acute agitation in a nonpsychiatric emergency department. The Primary Care Companion for CNS Disorders, 21(6), 19m02471. https://doi.org/10.4088/PCC.19m02471
   PubMedGoogle Scholar
• Kilbourne, A. M., & Pincus, H. A. (2006). Patterns of psychotropic medication use by race among veterans with bipolar disorder. Psychiatric Services (Washington, D.C.), 57(1), 123–126. https://doi.org/10.1176/appi.ps.57.1.123
   PubMed Web of Science ®Google Scholar
• Kishi, T., Ikuta, T., Matsuda, Y., Sakuma, K., Okuya, M., Nomura, I., Hatano, M., & Iwata, N. (2022). Pharmacological treatment for bipolar mania: A systematic review and network meta-analysis of double-blind randomized controlled trials. Molecular Psychiatry, 27(2), 1136–1144. https://doi.org/10.1038/s41380-021-01334-4
   PubMed Web of Science ®Google Scholar
• Kishi, T., Ikuta, T., Sakuma, K., Okuya, M., & Iwata, N. (2021). Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan. Journal of Psychiatric Research, 138, 444–452. https://doi.org/10.1016/j.jpsychires.2021.04.032
   PubMed Web of Science ®Google Scholar
• Kishimoto, T., Agarwal, V., Kishi, T., Leucht, S., Kane, J. M., & Correll, C. U. (2013). Relapse prevention in schizophrenia: A systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Molecular Psychiatry, 18(1), 53–66. https://doi.org/10.1038/mp.2011.143
   PubMed Web of Science ®Google Scholar
• Krause, M., Huhn, M., Schneider-Thoma, J., Rothe, P., Smith, R. C., & Leucht, S. (2018). Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 28(12), 1360–1370. https://doi.org/10.1016/j.euroneuro.2018.09.007
   PubMed Web of Science ®Google Scholar
• Kreyenbuhl, J., Zito, J. M., Buchanan, R. W., Soeken, K. L., & Lehman, A. F. (2003). Racial disparity in the pharmacological management of schizophrenia. Schizophrenia Bulletin, 29(2), 183–193. https://doi.org/10.1093/oxfordjournals.schbul.a006996
   PubMed Web of Science ®Google Scholar
• Kuno, E., & Rothbard, A. B. (2002). Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. The American Journal of Psychiatry, 159(4), 567–572. https://doi.org/10.1176/appi.ajp.159.4.567
   PubMed Web of Science ®Google Scholar
• Lawson, W., Johnston, S., Karson, C., Offord, S., Docherty, J., Eramo, A., Kamat, S., Blanchette, C. M., Carson, W., & Nasrallah, H. A. (2015). Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists, 27(4), 242–252.
   PubMed Web of Science ®Google Scholar
• Lentz, S. A., Walsh, K., & Long, B. (2022). Haloperidol may be safely administered intravenously in the emergency department. Annals of Emergency Medicine. Advance online publication. https://doi.org/10.1016/j.annemergmed.2022.07.004
   Google Scholar
• Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Orey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., Kissling, W., Stapf, M. P., Lässig, B., Salanti, G., & Davis, J. M. (2013). Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis. Lancet (London, England), 382(9896), 951–962. https://doi.org/10.1016/S0140-6736(13)60733-3
   PubMed Web of Science ®Google Scholar
• Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet (London, England), 373(9657), 31–41. https://doi.org/10.1016/S0140-6736(08)61764-X
   PubMed Web of Science ®Google Scholar
• López-Muñoz, F., & Alamo, C. (2009). The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Research Bulletin, 79(2), 130–141. https://doi.org/10.1016/j.brainresbull.2009.01.005
   PubMed Web of Science ®Google Scholar
• Metzl, J. M. (2012). Mainstream anxieties about race in antipsychotic drug ads. The Virtual Mentor: VM, 14(6), 494–502. https://doi.org/10.1001/virtualmentor.2012.14.6.imhl1-1206
   PubMedGoogle Scholar
• O’Brien, A. (2016). Comparing the risk of tardive dyskinesia in older adults with first-generation and second-generation antipsychotics: A systematic review and meta-analysis. International Journal of Geriatric Psychiatry, 31(7), 683–693. https://doi.org/10.1002/gps.4399
   PubMed Web of Science ®Google Scholar
• Opolka, J. L., Rascati, K. L., Brown, C. M., Barner, J. C., Johnsrud, M. T., & Gibson, P. J. (2003). Ethnic differences in use of antipsychotic medication among Texas Medicaid clients with schizophrenia. The Journal of Clinical Psychiatry, 64(6), 635–639. https://doi.org/10.4088/jcp.v64n0603
   PubMed Web of Science ®Google Scholar
• Ostuzzi, G., Bertolini, F., Del Giovane, C., Tedeschi, F., Bovo, C., Gastaldon, C., Nosé, M., Ogheri, F., Papola, D., Purgato, M., Turrini, G., Correll, C. U., & Barbui, C. (2021). Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: A network meta-analysis. The American Journal of Psychiatry, 178(5), 424–436. https://doi.org/10.1176/appi.ajp.2020.20071120
   PubMed Web of Science ®Google Scholar
• Owen, R. R., Feng, W., Thrush, C. R., Hudson, T. J., & Austen, M. A. (2001). Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatric Services (Washington, D.C.), 52(11), 1523–1525. https://doi.org/10.1176/appi.ps.52.11.1523
   PubMed Web of Science ®Google Scholar
• Patterson-Lomba, O., Ayyagari, R., & Carroll, B. (2019). Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: A retrospective data analysis. BMC Neurology, 19(1), 174. https://doi.org/10.1186/s12883-019-1385-4
   PubMedGoogle Scholar
• Pierre, J. M. (2020). Time to retire haloperidol? Current Psychiatry, 19(5), 18–28.
   Google Scholar
• Puyat, J. H., Daw, J. R., Cunningham, C. M., Law, M. R., Wong, S. T., Greyson, D. L., & Morgan, S. G. (2013). Racial and ethnic disparities in the use of antipsychotic medication: A systematic review and meta-analysis. Social Psychiatry and Psychiatric Epidemiology, 48(12), 1861–1872. https://doi.org/10.1007/s00127-013-0753-4
   PubMed Web of Science ®Google Scholar
• Puzantian, T., & Carlat, D. J. (2020). Medication fact book for psychiatric practice (5th ed.). Carlat Publishing, LLC.
   Google Scholar
• Salvo, F., Pariente, A., Shakir, S., Robinson, P., Arnaud, M., Thomas, S., Raschi, E., Fourrier-Réglat, A., Moore, N., Sturkenboom, M., Hazell on Behalf of Investigators of the Aritmo Consortium, L., & Investigators of the ARITMO Consortium. (2016). Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies. Clinical Pharmacology and Therapeutics, 99(3), 306–314. https://doi.org/10.1002/cpt.250
   PubMed Web of Science ®Google Scholar
• Samara, M. T., Dold, M., Gianatsi, M., Nikolakopoulou, A., Helfer, B., Salanti, G., & Leucht, S. (2016). Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: A network meta-analysis. JAMA Psychiatry, 73(3), 199–210. https://doi.org/10.1001/jamapsychiatry.2015.2955
   PubMed Web of Science ®Google Scholar
• Seeman, M. V. (2021). History of the dopamine hypothesis of antipsychotic action. World Journal of Psychiatry, 11(7), 355–364. https://doi.org/10.5498/wjp.v11.i7.355
   PubMed Web of Science ®Google Scholar
• Settle, E. C., & Ayd, F. J. (1983). Haloperidol: A quarter century of experience. The Journal of Clinical Psychiatry, 44(12), 440–448.
   PubMed Web of Science ®Google Scholar
• Shi, L., Ascher-Svanum, H., Zhu, B., Faries, D., Montgomery, W., & Marder, S. R. (2007). Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatric Services (Washington, D.C.), 58(4), 482–488. https://doi.org/10.1176/ps.2007.58.4.482
   PubMed Web of Science ®Google Scholar
• Smith, M., Hopkins, D., Peveler, R. C., Holt, R. I., Woodward, M., & Ismail, K. (2008). First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis. The British Journal of Psychiatry : The Journal of Mental Science, 192(6), 406–411. https://doi.org/10.1192/bjp.bp.107.037184
   PubMed Web of Science ®Google Scholar
• Solmi, M., Pigato, G., Kane, J. M., & Correll, C. U. (2018). Clinical risk factors for the development of tardive dyskinesia. Journal of the Neurological Sciences, 389, 21–27. https://doi.org/10.1016/j.jns.2018.02.012
   PubMed Web of Science ®Google Scholar
• Stegmayer, K., Walther, S., & van Harten, P. (2018). Tardive dyskinesia associated with atypical antipsychotics: Prevalence, mechanisms and management strategies. CNS Drugs, 32(2), 135–147. https://doi.org/10.1007/s40263-018-0494-8
   PubMed Web of Science ®Google Scholar
• Tyler, M. W., Zaldivar-Diez, J., & Haggarty, S. J. (2017). Classics in chemical neuroscience: Haloperidol. ACS Chemical Neuroscience, 8(3), 444–453. https://doi.org/10.1021/acschemneuro.7b00018
   PubMed Web of Science ®Google Scholar
• Vadiei, N., El-Ali, J., Delaune, J., Wild, C., & Liu, Y. S. (2022). Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia. Exploratory Research in Clinical and Social Pharmacy, 6, 100148. https://doi.org/10.1016/j.rcsop.2022.100148
   PubMedGoogle Scholar
• World Health Organization. (2021, September 30). WHO model list of essential medicines –22nd list, 2021. World Health Organization. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02
   Google Scholar
• Yang, M., Barner, J. C., Lawson, K. A., Rascati, K. L., Wilson, J. P., Crismon, M. L., Worchel, J., & Mascarenas, C. A. (2008). Antipsychotic medication utilization trends among Texas veterans: 1997-2002. The Annals of Pharmacotherapy, 42(9), 1229–1238. https://doi.org/10.1345/aph.1L155
   PubMed Web of Science ®Google Scholar
• Yang, C., Hao, Z., Tian, J., Zhang, W., Li, W., Zhang, L. L., & Song, F. (2018). Does antipsychotic drug use increase the risk of long term mortality? A systematic review and meta-analysis of observational studies. Oncotarget, 9(19), 15101–15110. https://doi.org/10.18632/oncotarget.24120
   PubMedGoogle Scholar
• Yee, C. S., Bahji, A., Lolich, M., Vázquez, G. H., & Baldessarini, R. J. (2022). Comparative efficacy and tolerability of antipsychotics for juvenile psychotic disorders: A systematic review and network meta-analysis. Journal of Clinical Psychopharmacology, 42(2), 198–208. https://doi.org/10.1097/JCP.0000000000001506
   PubMed Web of Science ®Google Scholar
• Zhang, J. P., Gallego, J. A., Robinson, D. G., Malhotra, A. K., Kane, J. M., & Correll, C. U. (2013). Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: A systematic review and meta-analysis. The International Journal of Neuropsychopharmacology, 16(6), 1205–1218. https://doi.org/10.1017/S1461145712001277
   PubMed Web of Science ®Google Scholar
• Zhu, Y., Krause, M., Huhn, M., Rothe, P., Schneider-Thoma, J., Chaimani, A., Li, C., Davis, J. M., & Leucht, S. (2017). Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: A systematic review with pairwise and network meta-analyses. The Lancet. Psychiatry, 4(9), 694–705. https://doi.org/10.1016/S2215-0366(17)30270-5
   PubMed Web of Science ®Google Scholar
• Zhu, Y., Zhang, C., Siafis, S., Zhuo, K., Zhu, D., Wu, H., Liu, D., Jiang, K., Wang, J., Leucht, S., & Li, C. (2021). Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis. Schizophrenia Research, 237, 20–25. https://doi.org/10.1016/j.schres.2021.08.013
   PubMed Web of Science ®Google Scholar